标题
A comprehensive approach to therapy of haematological malignancies in older patients
作者
关键词
-
出版物
Lancet Haematology
Volume 8, Issue 11, Pages e840-e852
出版商
Elsevier BV
发表日期
2021-10-06
DOI
10.1016/s2352-3026(21)00241-6
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Subcutaneous Rituximab-MiniCHOP Compared With Subcutaneous Rituximab-MiniCHOP Plus Lenalidomide in Diffuse Large B-Cell Lymphoma for Patients Age 80 Years or Older
- (2021) Lucie Oberic et al. JOURNAL OF CLINICAL ONCOLOGY
- Simplified Geriatric Assessment in Older Patients With Diffuse Large B-Cell Lymphoma: The Prospective Elderly Project of the Fondazione Italiana Linfomi
- (2021) Francesco Merli et al. JOURNAL OF CLINICAL ONCOLOGY
- Long-term outcomes of R-CEOP show curative potential in patients with DLBCL and a contraindication to anthracyclines
- (2021) Alden A. Moccia et al. Blood Advances
- Dose/Schedule-Adjusted Rd-R vs Continuous Rd for elderly, intermediate-fit, newly diagnosed multiple myeloma patients
- (2021) Alessandra Larocca et al. BLOOD
- Infection-related morbidity and mortality among older patients with DLBCL treated with full- or attenuated-dose R-CHOP
- (2021) Toby A. Eyre et al. Blood Advances
- Impact of R-CHOP dose intensity on survival outcomes in diffuse large B-cell lymphoma: a systematic review
- (2021) Edward J. Bataillard et al. Blood Advances
- Impact and safety of chimeric antigen receptor T cell therapy in older, vulnerable patients with relapsed/refractory large b-cell lymphoma
- (2020) Richard J. Lin et al. HAEMATOLOGICA
- Venetoclax plus LDAC for patients with untreated AML ineligible for intensive chemotherapy: phase 3 randomized placebo-controlled trial
- (2020) Andrew Henry Wei et al. BLOOD
- Geriatric assessment in older patients with a hematologic malignancy: a systematic review
- (2020) Ellen R.M. Scheepers et al. HAEMATOLOGICA
- Standard-of-Care Axicabtagene Ciloleucel for Relapsed or Refractory Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium
- (2020) Loretta J. Nastoupil et al. JOURNAL OF CLINICAL ONCOLOGY
- Acalabrutinib with or without obinutuzumab versus chlorambucil and obinutuzumab for treatment-naive chronic lymphocytic leukaemia (ELEVATE-TN): a randomised, controlled, phase 3 trial
- (2020) Jeff P Sharman et al. LANCET
- Geriatric assessment and survival among older adults receiving post-remission therapy for acute myeloid leukemia
- (2020) Mohammed Saad et al. BLOOD
- Tafasitamab plus lenalidomide in relapsed or refractory diffuse large B-cell lymphoma (L-MIND): a multicentre, prospective, single-arm, phase 2 study
- (2020) Gilles Salles et al. LANCET ONCOLOGY
- Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia
- (2020) Courtney D. DiNardo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and safety of frontline regimens for older transplant-ineligible patients with multiple myeloma: A systematic review and meta-analysis
- (2020) Smith Giri et al. Journal of Geriatric Oncology
- American Society of Hematology 2020 guidelines for treating newly diagnosed acute myeloid leukemia in older adults
- (2020) Mikkael A. Sekeres et al. Blood Advances
- Survival trends in elderly myeloma patients:
- (2020) Adam Jones et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Validation of the “fitness criteria” for the treatment of older patients with acute myeloid leukemia: A multicenter study on a series of 699 patients by the Network Rete Ematologica Lombarda (REL)
- (2020) Erika Borlenghi et al. Journal of Geriatric Oncology
- Fractures are common within 18 months following first-line R-CHOP in older patients with diffuse large B-cell lymphoma
- (2020) Stephen Booth et al. Blood Advances
- Priorities for the global advancement of care for older adults with cancer: an update of the International Society of Geriatric Oncology Priorities Initiative
- (2020) Martine Extermann et al. LANCET ONCOLOGY
- Oral Azacitidine Maintenance Therapy for Acute Myeloid Leukemia in First Remission
- (2020) Andrew H. Wei et al. NEW ENGLAND JOURNAL OF MEDICINE
- Approaches to aggressive B-cell lymphomas in less fit patients
- (2020) Nancy L. Bartlett Hematology-American Society of Hematology Education Program
- Impact of intended and relative dose intensity of R-CHOP in a large, consecutive cohort of elderly Diffuse large B cell lymphoma (DLBCL) patients treated with curative intent: no difference in cumulative incidence of relapse comparing patients by age
- (2019) Toby A. Eyre et al. JOURNAL OF INTERNAL MEDICINE
- Daratumumab plus Lenalidomide and Dexamethasone for Untreated Myeloma
- (2019) Thierry Facon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Revised Acute Myeloid Leukemia Composite Model Using the 2017 European LeukemiaNet Risk Classification
- (2019) Mohamed L. Sorror et al. JAMA Oncology
- Stand-alone intrathecal central nervous system (CNS) prophylaxis provide unclear benefit in reducing CNS relapse risk in elderly DLBCL patients treated with R-CHOP and is associated increased infection-related toxicity
- (2019) Toby A. Eyre et al. BRITISH JOURNAL OF HAEMATOLOGY
- Approaches for vulnerable and frail older patients with diffuse large B-cell lymphomas
- (2019) Pierre-Louis Soubeyran et al. CURRENT OPINION IN ONCOLOGY
- Venetoclax and Obinutuzumab in Patients with CLL and Coexisting Conditions
- (2019) Kirsten Fischer et al. NEW ENGLAND JOURNAL OF MEDICINE
- The efficacy and safety of venetoclax therapy in elderly patients with relapsed, refractory chronic lymphocytic leukaemia
- (2019) Toby A. Eyre et al. BRITISH JOURNAL OF HAEMATOLOGY
- Polatuzumab Vedotin in Relapsed or Refractory Diffuse Large B-Cell Lymphoma
- (2019) Laurie H. Sehn et al. JOURNAL OF CLINICAL ONCOLOGY
- Rituximab plus Bendamustine as front line treatment in frail elderly (>70 years) patients with diffuse large B-cell non-Hodgkin's lymphoma: a phase II multicenter study of the Fondazione Italiana Linfomi
- (2018) Sergio Storti et al. HAEMATOLOGICA
- Rituximab plus bendamustine or chlorambucil for chronic lymphocytic leukemia: primary analysis of the randomized, open-label MABLE study
- (2018) Anne-Sophie Michallet et al. HAEMATOLOGICA
- Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Chemotherapy: ASCO Guideline for Geriatric Oncology
- (2018) Supriya G. Mohile et al. JOURNAL OF CLINICAL ONCOLOGY
- Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America Clinical Practice Guideline Update
- (2018) Randy A. Taplitz et al. JOURNAL OF CLINICAL ONCOLOGY
- CPX-351 (cytarabine and daunorubicin) Liposome for Injection Versus Conventional Cytarabine Plus Daunorubicin in Older Patients With Newly Diagnosed Secondary Acute Myeloid Leukemia
- (2018) Jeffrey E. Lancet et al. JOURNAL OF CLINICAL ONCOLOGY
- Durable Remissions with Ivosidenib in IDH1-Mutated Relapsed or Refractory AML
- (2018) Courtney D. DiNardo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Daratumumab plus Bortezomib, Melphalan, and Prednisone for Untreated Myeloma
- (2018) María-Victoria Mateos et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rituximab plus Bendamustine as front line treatment in frail elderly (>70 years) patients with diffuse large B-cell non-Hodgkin's lymphoma: a phase II multicenter study of the Fondazione Italiana Linfomi
- (2018) Sergio Storti et al. HAEMATOLOGICA
- Rituximab plus bendamustine or chlorambucil for chronic lymphocytic leukemia: primary analysis of the randomized, open-label MABLE study
- (2018) Anne-Sophie Michallet et al. HAEMATOLOGICA
- Central nervous system relapse in patients over 80 years with diffuse large B-cell lymphoma: an analysis of two LYSA studies
- (2018) Aurélie Cabannes-Hamy et al. Cancer Medicine
- Incidence and survival of hematological cancers among adults ages ≥75 years
- (2018) Jessica L. Krok-Schoen et al. Cancer Medicine
- Prevalence of Cognitive Impairment and Association With Survival Among Older Patients With Hematologic Cancers
- (2018) Tammy T. Hshieh et al. JAMA Oncology
- Treatment of older patients with diffuse large B-cell lymphoma and mild cognitive impairment or dementia
- (2018) Christopher D. Saffore et al. Journal of Geriatric Oncology
- Outcome of patients aged 80 years or older treated for chronic lymphocytic leukaemia
- (2018) Othman Al-Sawaf et al. BRITISH JOURNAL OF HAEMATOLOGY
- Ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab in first-line treatment of chronic lymphocytic leukaemia (iLLUMINATE): a multicentre, randomised, open-label, phase 3 trial
- (2018) Carol Moreno et al. LANCET ONCOLOGY
- Randomized comparison of low dose cytarabine with or without glasdegib in patients with newly diagnosed acute myeloid leukemia or high-risk myelodysplastic syndrome
- (2018) Jorge E. Cortes et al. LEUKEMIA
- A simple score based on geriatric assessment predicts survival in elderly newly diagnosed chronic lymphocytic leukemia patients
- (2018) Stefano Molica et al. LEUKEMIA & LYMPHOMA
- Ibrutinib Regimens versus Chemoimmunotherapy in Older Patients with Untreated CLL
- (2018) Jennifer A. Woyach et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nonpegylated liposomal doxorubicin combination regimen in patients with diffuse large B-cell lymphoma and cardiac comorbidity. Results of the HEART01 phase II trial conducted by the Fondazione Italiana Linfomi
- (2017) Stefano Luminari et al. HEMATOLOGICAL ONCOLOGY
- Bortezomib with lenalidomide and dexamethasone versus lenalidomide and dexamethasone alone in patients with newly diagnosed myeloma without intent for immediate autologous stem-cell transplant (SWOG S0777): a randomised, open-label, phase 3 trial
- (2017) Brian G M Durie et al. LANCET
- Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation
- (2017) Richard M. Stone et al. NEW ENGLAND JOURNAL OF MEDICINE
- Combination of ofatumumab and reduced-dose CHOP for diffuse large B-cell lymphomas in patients aged 80 years or older: an open-label, multicentre, single-arm, phase 2 trial from the LYSA group
- (2017) Frédéric Peyrade et al. Lancet Haematology
- Effect of Intensive Chemotherapy on Physical, Cognitive, and Emotional Health of Older Adults with Acute Myeloid Leukemia
- (2016) Heidi D. Klepin et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- First-line chemoimmunotherapy with bendamustine and rituximab versus fludarabine, cyclophosphamide, and rituximab in patients with advanced chronic lymphocytic leukaemia (CLL10): an international, open-label, randomised, phase 3, non-inferiority trial
- (2016) Barbara Eichhorst et al. LANCET ONCOLOGY
- Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report
- (2015) A. Palumbo et al. BLOOD
- Chlorambucil plus ofatumumab versus chlorambucil alone in previously untreated patients with chronic lymphocytic leukaemia (COMPLEMENT 1): a randomised, multicentre, open-label phase 3 trial
- (2015) Peter Hillmen et al. LANCET
- Evaluation of geriatric assessment in patients with chronic lymphocytic leukemia: Results of the CLL9 trial of the German CLL study group
- (2015) Valentin Goede et al. LEUKEMIA & LYMPHOMA
- Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia
- (2015) Jan A. Burger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Development and psychometric validation of a brief comprehensive health status assessment scale in older patients with hematological malignancies: The GAH Scale
- (2015) S. Bonanad et al. Journal of Geriatric Oncology
- Comprehensive geriatric assessment is an essential tool to support treatment decisions in elderly patients with diffuse large B-cell lymphoma: a prospective multicenter evaluation in 173 patients by the Lymphoma Italian Foundation (FIL)
- (2014) Alessandra Tucci et al. LEUKEMIA & LYMPHOMA
- Obinutuzumab plus Chlorambucil in Patients with CLL and Coexisting Conditions
- (2014) Valentin Goede et al. NEW ENGLAND JOURNAL OF MEDICINE
- Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia
- (2014) Richard R. Furman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Geriatric assessment predicts survival for older adults receiving induction chemotherapy for acute myelogenous leukemia
- (2013) H. D. Klepin et al. BLOOD
- De Novo Treatment of Diffuse Large B-Cell Lymphoma With Rituximab, Cyclophosphamide, Vincristine, Gemcitabine, and Prednisolone in Patients With Cardiac Comorbidity: A United Kingdom National Cancer Research Institute Trial
- (2013) Paul A. Fields et al. JOURNAL OF CLINICAL ONCOLOGY
- Zoledronic Acid for Prevention of Bone Loss in Patients Receiving Primary Therapy for Lymphomas: A Prospective, Randomized Controlled Phase III Trial
- (2012) Jason R. Westin et al. Clinical Lymphoma Myeloma & Leukemia
- Attenuated immunochemotherapy regimen (R-miniCHOP) in elderly patients older than 80 years with diffuse large B-cell lymphoma: a multicentre, single-arm, phase 2 trial
- (2011) Frédéric Peyrade et al. LANCET ONCOLOGY
- Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project
- (2010) M. Sant et al. BLOOD
- How I treat elderly patients with diffuse large B-cell lymphoma
- (2010) M. Pfreundschuh BLOOD
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now